Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ALGN Align Technology | ABT Abbott Laboratories |
|---|---|---|
| Price | $147.61 -1.4% | $102.61 +0.4% |
| StockIQ Score | 36F Weak Risk: High | 51C- Moderate Risk: Medium |
| Technical | 9F | 19F |
| Fundamental | 64C+ | 72B |
| Growth | 42D | 45D+ |
| Fair Value | 38F | 38F |
| News | 26F | 100A+ |
| Quality | 42D | 63C+ |
| Risk | 42D | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Abbott Laboratories (ABT) outperforms Align Technology (ALGN) in most categories. ABT has a stronger investor score (56 vs. 42) and a higher fundamental score (72 vs. 64), indicating better underlying financial health. Its technical score (50 vs. 15) also suggests stronger short-term market performance. Both share the same valuation score of 38, but ABT’s moderate rating contrasts with ALGN’s weak rating.